International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
Kian Fan Chung, Sally E Wenzel, Jan L Brozek...
https://pubmed.ncbi.nlm.nih.gov/24337046/Actively Recruiting
Led by Societa Italiana di Pneumologia · Updated on 2023-11-28
20000
Participants Needed
1
Research Sites
600 weeks
Total Duration
This research aims to observe adults with mild and moderate asthma in real-world conditions to understand how the disease evolves in relation to current and future treatments. It focuses on patients diagnosed by specialists following the Global Initiative for Asthma GINA guidelines and seeks to collect a large group of participants for long-term observation. The study is sponsored by Societa Italiana di Pneumologia and is designed as an observational registry without interventional treatments. Participants attend scheduled visits at respiratory or allergy clinics, with follow-up visits planned every 6 or 12 months according to GINA guidelines and each centers plan. The study does not involve specific drugs or treatments but monitors patients receiving usual care under real-life conditions. The observation period extends up to 10 years from the date the last patient is enrolled, allowing for a comprehensive view of asthma management and progression. During the study, participants undergo regular assessments to evaluate asthma control, exacerbations, patient-reported outcomes, and the impact of various factors such as infections, vaccinations, lifestyle, and treatment techniques. Researchers also collect data on costs, digital therapy use, and socio-demographic influences. Safety monitoring and long-term follow-up are included, with participants continuing their usual care throughout the study period.
CONDITIONS
MANI Real-life Perspective Observatory
F
Fulvio Braido
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Societa Italiana di Pneumologia
Lead Sponsor
Società Italiana di Allergologia, Asma e Immunologia Clinica
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants who undergo routine care are observed with scheduled follow-up visits according to clinical guidelines and center plans.
Follow-up visits every 6 or 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Kian Fan Chung, Sally E Wenzel, Jan L Brozek...
https://pubmed.ncbi.nlm.nih.gov/24337046/Fulvio Braido, Francesco Blasi, Giorgio Walter Canonica...
https://pubmed.ncbi.nlm.nih.gov/34469268/Societa Italiana di Pneumologia
Lead Sponsor
Società Italiana di Allergologia, Asma e Immunologia Clinica
Collaborating Sponsor